$25 Million Damage Award in Accutane Trial

 

Andrew McCarrell has just been awarded $25.16 million in a defective drug claim for injuries sustained using Accutane. Roche Holding AG, the pharmaceutical company that manufactures Accutane, must pay the damage award.

McCarrell took Accutane to treat acne in 1995. He developed inflammatory bowel disease from taking the drug, resulting in five surgeries, including one to remove his colon. His lawsuit claims that Roche failed to provide an adequate warning of the risks associated with Accutane.

This verdict is the largest award in an Accutane trial to date. Currently, there are more than 1,000 defective drug lawsuits pending against Accutane. Roche pulled the drug from the market last summer, claiming generic drug competition and the excessive cost of defending pharmaceutical liability lawsuits fueled the decision.

Since its introduction to the market in 1982, more than 13 million people have used the acne medication. Over the years, it has been associated with an increased risk of inflammatory bowel disease, birth defects, and depression.

Roche plans on appealing the verdict, claiming the damage award was not substantiated by the evidence. The company stands by its assertion that they provided appropriate warnings regarding the risks associated with Accutane.

If you have suffered an injury as a result of taking Accutane, you may be entitled to recover compensation in a defective drug lawsuit. An experienced pharmaceutical injury attorney can help you receive what you rightfully deserve.